INBP Stock: Integrated BioPharma, Inc. Stock Price, Analysis & Insights

Get live INBP stock price $0.18, comprehensive Integrated BioPharma, Inc. stock analysis, charts, news, and expert forecast. Real-time INBP stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

0.18

0.00%Today

INBP • Integrated BioPharma, Inc. • Other OTC • Consumer Defensive

Market Cap

5.59M

Volume

8.14K

52W High

0.42

52W Low

0.17

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Integrated BioPharma, Inc. (INBP), along with its subsidiaries, focuses on the creation, distribution, promotion, and sale of vitamins, nutritional supplements, and herbal items. Its primary markets are the United States, Luxembourg, and Canada. The ...

Contact Information

Website: https://www.ibiopharma.com
Address: Building 15
Country: US

Investment Analysis & Business Insights

Consumer Defensive

Packaged Foods

Investment Highlights

✓ Strong presence in the Consumer Defensive sector with established market position

✓ Lower volatility stock (Beta: 0.24) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Integrated BioPharma, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Consumer Defensive may affect company performance
⚠Past performance does not guarantee future results for Integrated BioPharma, Inc.
⚠Investors should consider how Integrated BioPharma, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

5.59M

P/E Ratio (TTM)

-3.60

Beta

0.24

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.